For pharmacies, a new and separate application is required if there is a change of DBA name, ownership (parent/direct), or physical location. A new application is not required for a change in pharmacist-in-charge; however, a notification of this change is required within 10 days using form #08-4064.

For wholesale drug distributors undergoing a change in physical location, ownership, or facility manager, the new facility manager must submit a notification of change in manager using form #08-4064. The facility manager must also submit a completed fingerprint card and resumes of all officers, directors, or primary stakeholders. These must be submitted within 30 days of the change(s).

For outsourcing facilities and third-party logistics providers undergoing a change in name, physical location, ownership, or facility manager, a new and separate application is required. If the change involves a change in facility manager, an incoming and ongoing notice of this change must accompany the application using forms #08-4064 and #08-4285. The change in facility manager notification must be submitted within 10 days.

Unless a timeframe is specified (e.g.: 30 days for wholesale drug distributor changes), the license or registration is not eligible for renewal. If a timeframe is specified, it may be renewed. Here is an acceptable scenario: for a wholesale drug distributor that has changed its location on December 15 and submitted a renewal application on December 31, the existing license could be renewed on January 1 even though the address is no longer correct because the regulation allows for 30 days, in this example until January 14, to submit the notice of change documents.

No. A pharmacy technician must work under the direct supervision of a pharmacist in accordance with 12 AAC 52.230. “Direct supervision” is defined in 12 AAC 52.995(a)(13) and applies only in the context of a telepharmacy system for the remote pharmacy license category.

So long as the sole purpose and intent of the person used to deliver the prescriptions is to only deliver prescriptions to the patient, they do not need a pharmacy technician license.

No, the board does not regulate point-of-care testing as these are promulgated by the Alaska Department of Health and Social Services (DHSS) under the Clinical Laboratory Improvement Amendments (CLIA) program. For more information, please visit DHSS' Division of Public Health website.

Approved biosimilar and interchangeable products can be found at the FDA's Biosimilar Product Information Webpage.

No, the board does not have the authority to regulate the sale of OTC products as explicitly provided in AS 08.80.045. The board only has authority to require a license for third-party logistics providers transporting prescription drugs under AS 08.80.159, so if the products being transported only include OTC products, a license is not required.

No, the board does not require a reverse distributor to become licensed in Alaska so long as the facility is not selling or intending to sell the substances.

While the board does not have this requirement under AS 08.80 or 12 AAC 52, it is recommended by the Centers for Medicare and Medicaid Services (CMS) that written prescriptions be on tamper-resistant script pads. Pharmacies should follow the Medicaid Tamper Resistant Prescription Law, which states that as of April 2, 2008, a prescription must contain at least one of the following measures to be considered tamper resistant: feature designed to prevent unauthorized copying of a completed or blank prescription form; features designed to prevent the modification or removal of information written on the prescription pad; or features designed to prevent the use of counterfeit prescriptions. If in doubt of the legitimacy of the prescription, please communicate with the prescribing practitioner.

During the board’s November 15, 2019, the board reviewed 12 AAC 52.240, which requires drugs and devices to be kept in the prescription department. According to this regulation, the board opined that automated dispensing cabinets/kiosks would not be allowed.

During the board’s November 15th, 2019 meeting, the board voted to propose a new section for nationally certified technicians, including the ability for them to engage in the transfer of non-controlled substance prescriptions between two pharmacies per 12 AAC 52.500.

Pharmacists and pharmacy interns can independently administer immunizations or an epinephrine injection or other medication for the treatment of a severe allergic reaction only after completion of required training accredited by the Accreditation Council for Pharmacy Education (ACPE) and completion of cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED) training. The full list of requirements can be found under AS 08.80.168, 12 AAC 52.992, and 7 AAC 27.650 under the Department of Health and Social Services (see the VacTrAK document here). The independent administration of immunizations or related emergency medications does not require prior board approval. The board also does not require pharmacists or pharmacy interns to submit to our department documentation of successful completion of these courses; however, pharmacists supervising an intern planning to engage in providing immunizations or related emergency medications should use their due diligence to ensure the pharmacy intern has complied with the training requirements. Only pharmacy interns whose supervising pharmacists prescribe the immunization or related emergency medication and otherwise comply with 12 AAC 52.992 can engage in this activity.

Licensees wishing to engage in the continuous administration of immunizations and related emergency medications must participate in one hour of continuing education activity in accordance with 12 AAC 52.320(e)

Applications for Initial License, License Renewals, Reinstatement of Lapsed License, Collaborative Practice, Change in PIC/Pharmacy Manager and Self Inspections are accessible via our Applications and Forms webpage.

Forms for Change of Name, Change of Address, Verification of License, Duplicate License Request, Credit Card Payment and Exemption from SSN Requirements are located under “Important Links” on the Professional Licensing home page.

If your application is incomplete you will be notified by mail or email as soon as your application is reviewed. Please allow three to four weeks from the date the application is received for your status letter to reach you.

This is accomplished via a board-approved Collaborative Practice Plan. See Forms and Instructions, above.

To obtain a Certified True Copy, take the original document and a photocopy to a notary public so he/she may compare the original to the photocopy of the document. Either the applicant or the notary must write, "I certify this to be a true copy of the original document" on the photocopy and attest to that fact by signing the document and having it notarized.

In all of these cases, the facility needs to acquire a new license and new license number. This is done by completing the appropriate application.

Carefully read the instructions in this section of the application. It will instruct you to submit a letter of self explanation and a copy of the legal/court/board documents addressing the conviction. When your application is complete, it will be forwarded to Investigations for review. It will then be reviewed by a quorum of Board of Pharmacy members who will make the final licensing decision.

• Survey of Pharmacy Law: Dispensing Authority by the NABP

All DME vendors must have an Alaska Business License. If you also ship prescription medications directly to Alaska residents (vs. shipping to a facility), you are also required to be licensed by the Board of Pharmacy.

No. Any document that is notarized or has a board seal cannot be faxed or scanned. Submit documents via the postal mail.

1. Go to the homepage for Corporations, Business and Professional Licensing.
2. Choose the Professional Licensing Box.
3. Under Important Links, select Download List of License Holders
4. Select Pharmacy from the drop down list of professions & hit continue.
5. Make the selection you want from Step 2 and Step 3
6. Enter the email address to send the information in Step 4 AND choose Get Count and email the Data OR Give me a Count

View the new FAQs document for more information.

The most commonly asked questions for those applying for an Alaska Pharmacist License are answered by the Guide to Obtaining an Alaska Pharmacist License . Please refer to this first, then contact the Board of Pharmacy for further questions.

Click the orange button at the top of this page. Note the “board” abbreviation is PHA. You have to open the Click Here dialogue box if you will be entering a License Type to find the correct abbreviation.

Yes, licensing records are public documents and available to members of the public upon written request and payment of copying fees. Information considered confidential and not releasable to the general public include social security numbers and other information considered confidential by state or federal law. Your address of record is public information and is displayed on the division’s online License Search. Licensees have expressed concern that their address is so readily available. Some licensees have elected to have a post office box or practice location for their official address of record to avoid having their residential address easily accessible. Please be advised that all notices from the Board (renewal notices, licenses, and other legal documents) will be mailed to the address of record provided.

Contact the Board of Pharmacy licensing examiner for temporary permit requirements or read 12 AAC 52.100 in the Pharmacy Statutes and Regulations book.

The answer in Alaska is fairly simple. The law generally requires for a prescription to be valid, it must be written by a properly licensed prescriber, written in the normal ordinary course of practice, for an actual patient of that prescriber, and be for a legitimate medical reason. Thus, so long as the prescriber’s license was valid when the prescription was written for his/her patient (with whom there was an actual provider-patient relationship), the prescription was written in the usual course of practice, and it is for a legitimate medical reason, then the prescription may be filled. The same analysis applies for refills. For a quick example, Dr. Jones writes a prescription for his patient, Mr. Smith on April 6, 2016, with three refills. The next day, on April 7, Dr. Jones surrenders his license and DEA registration. If Mr. Smith presents the prescription and the pharmacist believes it was written in the usual course and for a legitimate medical purpose, the prescription and refills may be honored. It the same if the prescriber should become deceased.

• License Requirements for Individual Pharmacists Working for Tribal Health Programs

• HB 159 Letter of Clarification from the Chair

Yes, although there is no Alaska state specific regulation requiring identification to be shown, there is guidance from the Drug Enforcement Administration on the federal level that states a pharmacist may ask for proper identification.

Application by license transfer is different from the score transfer process. The license transfer application in actuality is to apply by reciprocity under AS 08.80.145 and requires the applicant to apply with the NABP for a license transfer to be sent to the Alaska Board of Pharmacy. The license transfer document made available to the board will show whether the applicant passed the NAPLEX and for which jurisdiction the examination was taken. This will suffice for documentation of the NAPLEX exam results required under 12 AAC 52.095. The NABP’s score transfer program is intended for applicants applying by examination under 12 AAC 52.070 and allows pharmacist license applicants to arrange for a NAPLEX score report transfer from a jurisdiction in which this exam was previously and successfully taken. Alaska Board of Pharmacy regulation allows score transfers under 12 AAC 52.090(c), which requires the applicant to arrange with the NABP the transfer of a NAPLEX score to the Alaska Board of Pharmacy. If pursuing this option, please indicate this on your application. Please note that the score transfer option is only available to applicants who have taken the NAPLEX within 90 days as the NABP only makes available these scores for that time period. If the date of which you will be submitting your application has surpassed this 90-day timeframe, please do not indicate this application option.

There is currently no restriction as to how many pharmacies an individual PIC can be in charge of. Although it is only specified for remote pharmacies under 12 AAC 52.425 that a PIC can be a PIC for more than one remote pharmacies, similar language is not found for pharmacies in general. Pharmacists who choose to be personally responsible for more than one pharmacy can do so at their discretion, but must be knowledgeable of all their responsibilities under AS 08, 12 AAC 52, and applicable federal law. If you will be an incoming PIC of an existing licensed pharmacy, please note you must submit the applicable form #08-4064 within 10 days of the appointment as PIC.